|
15.06.2018 02:30:00
|
Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed.
BOSTON, June 14, 2018 /PRNewswire/ -- Kyros Law Offices is alerting individuals that have suffered serious side effects from taking Invokana that it is investigating filing legal claims seeking compensation for their injuries. According to a February 22nd filing with the U.S. & Securities and Exchange Commission, Johnson & Johnson (NYSE: JNJ) and its Janssen Pharmaceuticals unit have been named defendants in approximately 1,100 lawsuits involving Invokana.
Invokana users that suffered serious side effects while taking Invokana are urged to contact our law firm immediately to protect their rights. Visit our Invokana Side Effect Lawsuit webpage or call 1-800-934-2921 to speak to someone about your case.
Hundreds of Invokana lawsuits have been centralized in the U.S. District Court, District of New Jersey, with hundreds of additional Invokana lawsuits pending in various state courts. These lawsuits allege that users of Invokana suffered serious side effects such as Diabetic Ketoacidosis, Kidney Injury, Limb Amputations and Heart Complications.
Kyros Law Offices urges Invokana users that suffered serious side effects while taking Invokana to contact our law firm immediately to protect their rights. Visit our Invokana Side Effect Lawsuit webpage or call 1-800-934-2921 to speak to someone about your case.
Receive alerts about other potential class action lawsuits that may affect you by visiting the Class Action Lawsuit Center website.
Kyros Law specializes in a wide range of complex litigation, mass torts, and corporate governance matters, including the representation of whistleblowers, shareholders and consumers in securities fraud, false claims act and class actions. Our lawyers have been responsible for recovering hundreds of millions of dollars for our clients throughout the United States, Africa, Asia and Europe. Visit our website to learn more about our firm.
View original content:SOURCE Kyros Law
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
|
18.12.24 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Verlust hätte ein Investment in Johnson Johnson von vor einem Jahr eingebracht (finanzen.at) | |
|
17.12.24 |
Dow Jones-Handel aktuell: Dow Jones legt zum Handelsende den Rückwärtsgang ein (finanzen.at) | |
|
17.12.24 |
NYSE-Handel Dow Jones am Dienstagnachmittag mit Abgaben (finanzen.at) | |
|
17.12.24 |
Dow Jones-Handel aktuell: Dow Jones fällt (finanzen.at) | |
|
16.12.24 |
Schwacher Handel in New York: Dow Jones schlussendlich in Rot (finanzen.at) | |
|
11.12.24 |
Angespannte Stimmung in New York: Dow Jones beendet die Mittwochssitzung im Minus (finanzen.at) | |
|
11.12.24 |
Schwache Performance in New York: Dow Jones notiert nachmittags im Minus (finanzen.at) | |
|
11.12.24 |
Zuversicht in New York: Dow Jones mit Kursplus (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.